Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 4–4 | Cite as

Serious thromboembolic events with liposomal irinotecan

News item
  • 32 Downloads

Reference

  1. Medicines and Healthcare products Regulatory Agency (UK). Onivyde (irinotecan, liposomal formulations): reports of serious and fatal thromboembolic events. Drug Safety Update 12: 6-7, No. 8, Mar 2019. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/787952/March-2019-PDF-final.pdf Google Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations